Market Overview:
The global medical specialty enzymes market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The market was valued at USD 1,711 million in 2018 and is projected to reach USD 2,817 million by 2030. Oxidoreductases had the biggest market share of 45% in 2018. Immunoassays is the greatest segment of Medical Specialty Enzymes application, with a share of 28% in 2018. North America had the largest share of the global medical specialty enzymes market in 2018 and is projected to maintain its dominance during the forecast period.
Product Definition:
Medical specialty enzymes are a type of enzyme that is used specifically in the medical field. They are often used to help diagnose or treat medical conditions. Enzymes are important because they play a role in many different biochemical processes in the body.
Oxidoreductases:
oxidoreductases, it's usage.
The oxidoreductases, it's usage and growth factor in the medical specialty enzymes market size was valued at USD 843.7 million in 2015. The rising prevalence of chronic diseases such as cancer & diabetes along with increasing demand for enzyme replacement therapies are expected to drive the industry over the forecast period.
Transferases:
Transferases are enzymes that act on phospholipids to transfer the phosphate group. They are used in medical specialty enzymes for treatment of diseases such as myocardial infarction, stroke, and peripheral vascular disease. These products find application in research activities for development of novel drugs and biologics.
Application Insights:
The others segment includes amino acid analysis, blood gas testing, drug testing, genetic tests and toxicology analyzes. The other application segments are anticipated to witness the fastest growth over the forecast period owing to rising demand for specialty enzymes in various academic research studies and clinical applications. For instance, COVID19 is a highly pathogenic version of SARS-CoV-2 that caused a global pandemic in 2018. This virus spreads rapidly through respiratory droplets generated by close contact between two people with healthy lungs. Thus far no vaccine or treatment has been found to prevent or treat this disease effectively; however many research studies are being conducted regarding possible treatments using Medical Specialty Enzymes such as Polymerase Chain Reaction (PCR).
Regional Analysis:
North America dominated the global market in 2018. This can be attributed to the presence of a large number of key players, high disposable income and healthcare expenditure, and increasing adoption of advanced diagnostic technologies. In addition, growing focus on drug discovery & development activities by major pharmaceutical companies is expected to drive growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising demand for medical tests that require specialized enzymes in countries such as India and China. Moreover, an increase in research funding for diseases prevalent within this region has led to an increase in studies conducted with these enzymes; which will further boost revenue generation over the next eight years (from 2018’to 2030).
Growth Factors:
- Increasing demand for enzymes in the pharmaceutical and biotechnology industries for drug discovery and development.
- Growing demand from the food and beverage industry for specialty enzymes that improve product quality, taste, and shelf life.
- Rising incidence of chronic diseases such as cancer, diabetes, and cardiovascular diseases that require treatment with specialty enzymes.
- Rapid growth in the number of aging population worldwide who are susceptible to chronic diseases that require enzyme therapy treatments.
Scope Of The Report
Report Attributes
Report Details
Report Title
Medical Specialty Enzymes Market Research Report
By Type
Oxidoreductases, Transferases, Others, Oxidoreductases had the biggest market share of 45% in 2018.
By Application
Immunoassays, Clinical Chemistry, Others, Immunoassays is the greatest segment of Medical Specialty Enzymes application, with a share of 28% in 2018.
By Companies
Amano Enzymes, Sekisui, Novozymes, Roche CustomBiotech, BBI Solutions, Advanced Enzymes Technologies, Codexis, Biocatalysts, Amicogen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Medical Specialty Enzymes Market Report Segments:
The global Medical Specialty Enzymes market is segmented on the basis of:
Types
Oxidoreductases, Transferases, Others, Oxidoreductases had the biggest market share of 45% in 2018.
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Immunoassays, Clinical Chemistry, Others, Immunoassays is the greatest segment of Medical Specialty Enzymes application, with a share of 28% in 2018.
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Amano Enzymes
- Sekisui
- Novozymes
- Roche CustomBiotech
- BBI Solutions
- Advanced Enzymes Technologies
- Codexis
- Biocatalysts
- Amicogen
Highlights of The Medical Specialty Enzymes Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oxidoreductases
- Transferases
- Others
- Oxidoreductases had the biggest market share of 45% in 2018.
- By Application:
- Immunoassays
- Clinical Chemistry
- Others
- Immunoassays is the greatest segment of Medical Specialty Enzymes application, with a share of 28% in 2018.
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Medical Specialty Enzymes Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Medical specialty enzymes are specific proteins that help to break down complex molecules in the body. These proteins can be used to treat a variety of medical conditions, including cancer and heart disease.
Some of the major players in the medical specialty enzymes market are Amano Enzymes, Sekisui, Novozymes, Roche CustomBiotech, BBI Solutions, Advanced Enzymes Technologies, Codexis, Biocatalysts, Amicogen.
The medical specialty enzymes market is expected to grow at a compound annual growth rate of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Medical Specialty Enzymes Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Medical Specialty Enzymes Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Medical Specialty Enzymes Market - Supply Chain
4.5. Global Medical Specialty Enzymes Market Forecast
4.5.1. Medical Specialty Enzymes Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Medical Specialty Enzymes Market Size (000 Units) and Y-o-Y Growth
4.5.3. Medical Specialty Enzymes Market Absolute $ Opportunity
5. Global Medical Specialty Enzymes Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Medical Specialty Enzymes Market Size and Volume Forecast by Type
5.3.1. Oxidoreductases
5.3.2. Transferases
5.3.3. Others
5.3.4. Oxidoreductases had the biggest market share of 45% in 2018.
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Medical Specialty Enzymes Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Medical Specialty Enzymes Market Size and Volume Forecast by Application
6.3.1. Immunoassays
6.3.2. Clinical Chemistry
6.3.3. Others
6.3.4. Immunoassays is the greatest segment of Medical Specialty Enzymes application, with a share of 28% in 2018.
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Medical Specialty Enzymes Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Medical Specialty Enzymes Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Medical Specialty Enzymes Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Medical Specialty Enzymes Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Medical Specialty Enzymes Demand Share Forecast, 2019-2026
9. North America Medical Specialty Enzymes Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Medical Specialty Enzymes Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Medical Specialty Enzymes Market Size and Volume Forecast by Application
9.4.1. Immunoassays
9.4.2. Clinical Chemistry
9.4.3. Others
9.4.4. Immunoassays is the greatest segment of Medical Specialty Enzymes application, with a share of 28% in 2018.
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Medical Specialty Enzymes Market Size and Volume Forecast by Type
9.7.1. Oxidoreductases
9.7.2. Transferases
9.7.3. Others
9.7.4. Oxidoreductases had the biggest market share of 45% in 2018.
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Medical Specialty Enzymes Demand Share Forecast, 2019-2026
10. Latin America Medical Specialty Enzymes Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Medical Specialty Enzymes Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Medical Specialty Enzymes Market Size and Volume Forecast by Application
10.4.1. Immunoassays
10.4.2. Clinical Chemistry
10.4.3. Others
10.4.4. Immunoassays is the greatest segment of Medical Specialty Enzymes application, with a share of 28% in 2018.
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Medical Specialty Enzymes Market Size and Volume Forecast by Type
10.7.1. Oxidoreductases
10.7.2. Transferases
10.7.3. Others
10.7.4. Oxidoreductases had the biggest market share of 45% in 2018.
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Medical Specialty Enzymes Demand Share Forecast, 2019-2026
11. Europe Medical Specialty Enzymes Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Medical Specialty Enzymes Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Medical Specialty Enzymes Market Size and Volume Forecast by Application
11.4.1. Immunoassays
11.4.2. Clinical Chemistry
11.4.3. Others
11.4.4. Immunoassays is the greatest segment of Medical Specialty Enzymes application, with a share of 28% in 2018.
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Medical Specialty Enzymes Market Size and Volume Forecast by Type
11.7.1. Oxidoreductases
11.7.2. Transferases
11.7.3. Others
11.7.4. Oxidoreductases had the biggest market share of 45% in 2018.
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Medical Specialty Enzymes Demand Share, 2019-2026
12. Asia Pacific Medical Specialty Enzymes Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Medical Specialty Enzymes Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Medical Specialty Enzymes Market Size and Volume Forecast by Application
12.4.1. Immunoassays
12.4.2. Clinical Chemistry
12.4.3. Others
12.4.4. Immunoassays is the greatest segment of Medical Specialty Enzymes application, with a share of 28% in 2018.
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Medical Specialty Enzymes Market Size and Volume Forecast by Type
12.7.1. Oxidoreductases
12.7.2. Transferases
12.7.3. Others
12.7.4. Oxidoreductases had the biggest market share of 45% in 2018.
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Medical Specialty Enzymes Demand Share, 2019-2026
13. Middle East & Africa Medical Specialty Enzymes Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Medical Specialty Enzymes Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Medical Specialty Enzymes Market Size and Volume Forecast by Application
13.4.1. Immunoassays
13.4.2. Clinical Chemistry
13.4.3. Others
13.4.4. Immunoassays is the greatest segment of Medical Specialty Enzymes application, with a share of 28% in 2018.
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Medical Specialty Enzymes Market Size and Volume Forecast by Type
13.7.1. Oxidoreductases
13.7.2. Transferases
13.7.3. Others
13.7.4. Oxidoreductases had the biggest market share of 45% in 2018.
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Medical Specialty Enzymes Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Medical Specialty Enzymes Market: Market Share Analysis
14.2. Medical Specialty Enzymes Distributors and Customers
14.3. Medical Specialty Enzymes Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Amano Enzymes
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sekisui
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Novozymes
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Roche CustomBiotech
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. BBI Solutions
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Advanced Enzymes Technologies
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Codexis
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Biocatalysts
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Amicogen
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
